最近，国家药品审评中心张象麟主任、武志昂主任助理及中心各部部长深入山东科研生产一线进行了调查研究和现场考察，与一线科研人员共同探讨新药研究、开发方面的宏观前景和具体措施。近年来，国家药品审评中心注重抓好作风建设，适应加入WTO和新修订《药品管理法》实施的新形 Recently, Zhang Xianglin, director of National Drug Evaluation Center and assistant director of Wu Zhiang and ministries and commissions of the central departments conducted in-depth investigations and field visits in Shandong scientific research and production production line and jointly discussed the macro-perspectives and specific measures in the research and development of new drugs with front-line scientific researchers. In recent years, the State Drug Evaluation Center pay attention to building a good style, to adapt to accession to the WTO and the newly revised “Drug Administration Law” to implement a new form